Dr. William Campbell receives PhRMA Foundation Award in Excellence
April 23, 2013 College News - William B. Campbell, PhD, Chairman and Professor of Pharmacology and Toxicology, has received the 2013 Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation Award in Excellence in Pharmacology/Toxicology. The award honors scientists whose foundation grant helped launch exemplary careers in academia, industry, and government.
The PhRMA Foundation presented the award to Dr. Campbell on April 20, at the American Society for Pharmacology and Experimental Therapeutics (ASPET) annual meeting in Boston.
“The PhRMA Foundation is proud of Dr. Campbell’s many accomplishments including his more than three decades of continuous support from the National Institutes of Health,” said Eileen Cannon, Executive Director of the PhRMA Foundation. “He has guided numerous graduate students over the years and continues to educate the next generation of scientists, we view him as an ideal recipient of our most prestigious award.”
Dr. Campbell completed his postdoctoral fellowship and training in renal physiology and prostaglandin pharmacology at the Medical College of Wisconsin. He received his BS in Pharmacy from the University of Texas at Austin in 1970 and his PhD in Pharmacology from the University of Texas Southwestern Medical Center four years later. In 1976, he joined the university’s Department of Pharmacology as an Assistant Professor and received a PhRMA Foundation (formerly, Pharmaceutical Manufacturers Association [PMA] Foundation) Research Starter Grant in Pharmacology/Toxicology. He was appointed Chair of Pharmacology and Toxicology at the Medical College of Wisconsin in 1992.
Over the past 30 years, Dr. Campbell’s research has focused on endothelium-derived factors that regulate blood pressure, adrenal steroidogenesis, and vascular tone. He received the 2006 Novartis Award from the American Heart Association (AHA) Council for High Blood Pressure Research and the 2010 Paul M. Vanhoutte Award in Vascular Pharmacology from ASPET—both for his work in the discovery of endothelial factors that regulate blood pressure. His research has been supported by grants from the National Heart, Lung, and Blood Institute; National Institute of Diabetes and Digestive and Kidney Diseases; and National Institute on Drug Abuse.
“The jump start to my research from PhRMA, then PMA, is greatly appreciated.” said Dr. Campbell. “The PMA Award provided funding at a critical time when I was just starting out as an assistant professor. It provided data for an independent research article as well as key data for my first NIH grant and an NIH Research Career Development Award. I have been continuously funded by NIH ever since, 34 years and counting.”
Dr. Campbell has served as a guest editor for Hypertension, Prostaglandins and Other Lipid Mediators, and the American Journal of Physiology, and is the North American receiving editor for Basic and Clinical Pharmacology and Toxicology. He has served on national committees for the AHA, AHA’s Council for High Blood Pressure Research, and ASPET. He was also a grant reviewer and member of the National Institutes of Health (NIH) Cardiovascular and Renal Study Section and is an ad hoc reviewer for the NIH, Veteran’s Administration Merit Review Program, Burroughs Wellcome Fund, and National Heart Foundation of Australia. He has written more than 320 research articles and book chapters.